Garrison Bradford & Associates’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.4K | Hold |
487
| – | – | 0.04% | 50 |
|
|
2025
Q1 | $39.5K | Buy |
+487
| New | +$39.5K | 0.04% | 50 |
|
|
2023
Q4 | – | Sell |
-2,955
| Closed | -$216K | – | 32 |
|
|
2023
Q3 | $216K | Hold |
2,955
| – | – | 0.26% | 28 |
|
|
2023
Q2 | $246K | Hold |
2,955
| – | – | 0.3% | 30 |
|
|
2023
Q1 | $225K | Hold |
2,955
| – | – | 0.28% | 34 |
|
|
2022
Q4 | $245K | Hold |
2,955
| – | – | 0.3% | 37 |
|
|
2022
Q3 | $234K | Sell |
2,955
-1,160
| -28% | -$91.9K | 0.28% | 40 |
|
|
2022
Q2 | $306K | Hold |
4,115
| – | – | 0.35% | 34 |
|
|
2022
Q1 | $370K | Sell |
4,115
-100
| -2% | -$8.99K | 0.36% | 34 |
|
|
2021
Q4 | $472K | Sell |
4,215
-590
| -12% | -$66.1K | 0.42% | 34 |
|
|
2021
Q3 | $604K | Hold |
4,805
| – | – | 0.61% | 27 |
|
|
2021
Q2 | $651K | Buy |
4,805
+300
| +7% | +$40.6K | 0.68% | 27 |
|
|
2021
Q1 | $611K | Buy |
4,505
+505
| +13% | +$68.5K | 0.68% | 28 |
|
|
2020
Q4 | $563K | Buy |
4,000
+700
| +21% | +$98.5K | 0.69% | 29 |
|
|
2020
Q3 | $368K | Sell |
3,300
-60
| -2% | -$6.69K | 0.52% | 30 |
|
|
2020
Q2 | $376K | Sell |
3,360
-150
| -4% | -$16.8K | 0.55% | 28 |
|
|
2020
Q1 | $272K | Sell |
3,510
-500
| -12% | -$38.7K | 0.47% | 31 |
|
|
2019
Q4 | $381K | Hold |
4,010
| – | – | 0.48% | 32 |
|
|
2019
Q3 | $306K | Buy |
4,010
+60
| +2% | +$4.58K | 0.42% | 35 |
|
|
2019
Q2 | $346K | Hold |
3,950
| – | – | 0.4% | 42 |
|
|
2019
Q1 | $358K | Buy |
+3,950
| New | +$358K | 0.3% | 54 |
|